Future studies are needed to confirm these findings, and to elucidate the mechanisms by which TET2 loss leads to reduced 5-hmC level in esophageal epithelial cells and subsequent ESCC development. The gene discussed is TET2; the disease is esophageal squamous cell carcinoma.